234 filings
Page 2 of 12
8-K
yrzshp1a7
12 Aug 21
Casi Pharmaceuticals Announces Second Quarter 2021
4:32pm
8-K
149vx
28 Jul 21
Departure of Directors or Certain Officers
4:01pm
8-K/A
mhtdu8rp9ni5 1h
21 Jun 21
Departure of Directors or Certain Officers
5:26pm
8-K
w1t z34evr8z1ljs4f
16 Jun 21
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
0kte1a
13 May 21
Casi Pharmaceuticals Announces First Quarter 2021 Financial Results
4:02pm
8-K
8f654u2
30 Apr 21
Departure of Directors or Certain Officers
4:01pm
8-K
ush9lsls
30 Mar 21
Announces Full Year 2020 Financial Results
12:00am
8-K
cbk1g
26 Mar 21
Casi Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:01pm
8-K
0rcrc6dawymadf2
25 Mar 21
Departure of Directors or Certain Officers
4:01pm
8-K
rluvpsyv8pjj
23 Mar 21
Other Events
4:04pm
8-K
slzt355 1tq7z
12 Mar 21
Corporate Presentation March 2021
9:20am
8-K
rcqcwm1f
8 Mar 21
Entry into a Material Definitive Agreement
4:01pm
8-K
hhbd5ewlyvwh0z
16 Feb 21
Casi Pharmaceuticals Announces Preliminary Fourth Quarter and Full-Year 2020 Revenues
4:01pm
8-K
kkfrkr l9oyx
10 Feb 21
Amendments to Articles of Incorporation or Bylaws
5:04pm
8-K
nx1 w3uzoaspyw8xbm
28 Jan 21
Casi Pharmaceuticals Partner, Bioinvent, Presents
4:02pm
8-K
rpmxzr ft
23 Dec 20
Receives China Breakthrough Therapy Designation
4:01pm
8-K
8scvbxkc agwg
16 Dec 20
Casi Pharmaceuticals Announces Appointment of Chief Financial Officer
4:43pm
8-K
wfwywiey
19 Nov 20
Casi Pharmaceuticals Announces Partner Juventas
4:05pm
8-K
bvd4ovqn93q
9 Nov 20
Casi Pharmaceuticals Announces Third Quarter 2020
4:30pm
8-K
rgjz ekccmpjwi0n3z
28 Oct 20
Entry into a Material Definitive Agreement
4:26pm